Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of triamterene-hydrochlorothiazide and hydrochlorothiazide in refractory edema
IRCT20111206008307N37Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of triamterene + hydrochlorothiazide and hydrochlorothiazide in heart failure (HF), heart failure with preserved ejection fraction (HFpEF) and edema (2 arms), sponsored by Tabriz University of Medical Sciences. Started Oct 2019; status: completed.
02
Drugs
triamterene + hydrochlorothiazidehydrochlorothiazide
03
Conditions
heart failure (HF)heart failure with preserved ejection fraction (HFpEF)edema
Beyond the preview
Go deeper on IRCT20111206008307N37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20111206008307N37.